Aug 2026
Continuous Glucose Monitoring and Automated Insulin Delivery in Infants with Type 1 Diabetes: Real-World Evidence to Support Future International Guidelines.
CGM is safe in very young children, with AID systems proving superior to traditional therapy, and real-world evidence supports incorporating AID consideration into future international guidelines from the time of pediatric diagnosis.
M. Marigliano, A. Scaramuzza, C. Arnaldi et al.
· Diabetes Technology & Therap... · 0 citations